{"podcast":{"title":"From Models to Medicine","slug":"from-models-to-medicine-7769799","podcast_index_feed_id":7769799,"rss_url":"https://anchor.fm/s/110164688/podcast/rss","website_url":"https://podcasters.spotify.com/pod/show/kami-think-tank","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/45548626/45548626-1773273198170-a0661f37581aa.jpg","author":"KAMI Think Tank","episode_count":19,"summary":"At KAMI Think Tank, we love cutting through the AI hype to showcase where the technology actually stands and how to use it meaningfully within the life sciences. Now, we're bringing that same clarity with our community to a brand new podcast: From Models to Medicine. Every week, we sit down with a real practitioner in the life sciences, whether they're working in the lab, leading innovation at a biotech, or building tools to better serve scientists. We discuss how they cut through the hype of AI and practically leverage the tool in their scientific workflows. Glad to have you here.","last_synced_at":"2026-07-30T04:19:36.234491+00:00","page_url":"https://stenobird.com/podcast/from-models-to-medicine-7769799"},"episode":{"title":"Episode 14: The Drug Discovery Problems AI Alone Can't Solve","slug":"episode-14-the-drug-discovery-problems-ai-alone-can-t-solve","published_at":"2026-06-24T14:52:00+00:00","page_url":"https://stenobird.com/podcast/from-models-to-medicine-7769799/episode-14-the-drug-discovery-problems-ai-alone-can-t-solve","show_page_url":"https://stenobird.com/podcast/from-models-to-medicine-7769799","url":"https://podcasters.spotify.com/pod/show/kami-think-tank/episodes/Episode-14-The-Drug-Discovery-Problems-AI-Alone-Cant-Solve-e3k3eli","audio_url":"https://anchor.fm/s/110164688/podcast/play/120748146/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-30%2F1ce81024-6c58-a377-7673-a9f6bba3d663.mp3","summary":"In this episode of From Models to Medicine, we speak with Vid Stojevic , the co-founder and CEO of Kuano, a Cambridge-based company using quantum algorithms and AI to tackle the drug discovery problems that traditional computational chemistry keeps failing. In this episode, he explains why he deliberately ignored the broad platform play and went narrow instead, targeting the specific early-stage problems where getting the physics right changes everything. We get into what a "quantum lens" actually means in practice, why transition states are a better design target than natural substrates, and how Kuano is succeeding on targets that pharma had written off as undruggable. Vid makes a sharp case for how generating synthetic quantum data turns a low-data drug discovery problem into something AI can actually work with. He closes with honest advice on when quantum simulation is the right tool and when it simply isn't.","meta_description":"In this episode of From Models to Medicine, we speak with Vid Stojevic , the co-founder and CEO of Kuano, a Cambridge-based company using quantum algorith…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2747,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/from-models-to-medicine-7769799/episodes/episode-14-the-drug-discovery-problems-ai-alone-can-t-solve/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/from-models-to-medicine-7769799/episode-14-the-drug-discovery-problems-ai-alone-can-t-solve.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}